Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 7:57 PM View:  | Bridgebio Pharma, Inc. (BBIO) | 19-Nov-24 | Private Sale (Planned) | 4,156 | $22.41 | $93,136.80 | (4%) 97.91K to 93.76K | |
| 19-Nov-24 6:06 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-24 | Payment of Exercise | 13,077 | $23.72 | $310,186.00 | (12%) 110.99K to 97.91K | |
| 19-Nov-24 6:06 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-24 | Option Exercise | 25,799 | -- | -- | 30% 85.19K to 110.99K | |
| 20-Aug-24 6:27 PM View: | Bridgebio Pharma, Inc. (BBIO) | 19-Aug-24 | Planned Option Sale | 4,155 | $24.69 | $102,590.00 | (5%) 89.35K to 85.19K | |
| 20-Aug-24 6:27 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-24 | Payment of Exercise | 13,077 | $24.40 | $319,079.00 | (13%) 102.42K to 89.35K | |
| 20-Aug-24 6:27 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-24 | Option Exercise | 25,797 | -- | -- | 34% 76.63K to 102.42K | |
| 17-May-24 4:09 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-24 | Payment of Exercise | 13,943 | $31.04 | $432,791.00 | (15%) 90.42K to 76.47K | |
| 17-May-24 4:09 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-24 | Option Exercise | 27,507 | -- | -- | 44% 62.91K to 90.42K | |
| 21-Feb-24 4:04 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Payment of Exercise | 18,919 | $37.21 | $703,976.00 | (23%) 81.83K to 62.91K | |
| 21-Feb-24 4:04 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Option Exercise | 44,996 | -- | -- | 122% 36.83K to 81.83K | |
| 20-Nov-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 17-Nov-23 | Planned Option Sale | 22,685 | $29.10 | $660,059.00 | (38%) 59.4K to 36.71K | |
| 20-Nov-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Payment of Exercise | 22,311 | $28.86 | $643,896.00 | (27%) 81.71K to 59.4K | |
| 20-Nov-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Option Exercise | 44,996 | -- | -- | 123% 36.71K to 81.71K | |
| 18-Aug-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 17-Aug-23 | Planned Option Sale | 22,683 | $28.59 | $648,455.00 | (38%) 59.39K to 36.71K | |
| 18-Aug-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-23 | Payment of Exercise | 22,311 | $29.80 | $664,868.00 | (27%) 81.7K to 59.39K | |
| 18-Aug-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-23 | Option Exercise | 44,994 | -- | -- | 123% 36.71K to 81.7K | |
| 18-May-23 4:02 PM View: | Bridgebio Pharma, Inc. (BBIO) | 17-May-23 | Planned Option Sale | 24,424 | $14.01 | $342,168.00 | (40%) 60.83K to 36.41K | |
| 18-May-23 4:02 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-23 | Payment of Exercise | 20,572 | $14.09 | $289,859.00 | (25%) 81.4K to 60.83K | |
| 18-May-23 4:02 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-23 | Option Exercise | 44,996 | -- | -- | 124% 36.41K to 81.4K | |
| 05-May-23 4:01 PM View: | Bridgebio Pharma, Inc. (BBIO) | 03-May-23 | Market Sale (Planned) | 64,929 | $14.18 | $920,693.00 | (64%) 101.34K to 36.41K | (< 1%) |
| 07-Apr-23 4:42 PM View: | Bridgebio Pharma, Inc. (BBIO) | 05-Apr-23 | Private Sale (Planned) | 55,500 | $15.45 | $857,697.00 | (35%) 156.84K to 101.34K | |
| 03-Mar-23 10:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 03-Mar-23 | Sale (Planned) | 62,692 | $10.96 | $687,148.00 | (29%) 219.53K to 156.84K | |
| 21-Feb-23 8:16 PM View: | Bridgebio Pharma, Inc. (BBIO) | 17-Feb-23 | Planned Option Sale | 17,717 | $12.70 | $225,066.00 | (7%) 237.25K to 219.53K | |
| 21-Feb-23 8:16 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-23 | Payment of Exercise | 9,910 | $12.64 | $125,262.00 | (4%) 247.16K to 237.25K | |
| 21-Feb-23 8:16 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-23 | Option Exercise | 27,627 | -- | -- | 13% 219.53K to 247.16K | |
| 06-Feb-23 7:43 PM View: | Bridgebio Pharma, Inc. (BBIO) | 03-Feb-23 | Sale (Planned) | 61,040 | $11.01 | $671,922.00 | (22%) 280.22K to 219.18K | |
| 06-Jan-23 8:38 PM View: | Bridgebio Pharma, Inc. (BBIO) | 05-Jan-23 | Sale (Planned) | 61,040 | $7.67 | $468,470.00 | (18%) 341.26K to 280.22K | |
| 18-Nov-22 6:40 PM View: | Bridgebio Pharma, Inc. (BBIO) | 17-Nov-22 | Option Sale | 19,678 | $9.40 | $184,985.00 | (5%) 360.94K to 341.26K | |
| 18-Nov-22 6:40 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-22 | Payment of Exercise | 10,789 | $9.64 | $104,006.00 | (3%) 371.73K to 360.94K | |
| 18-Nov-22 6:40 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-22 | Option Exercise | 30,467 | -- | -- | 9% 341.26K to 371.73K | |
| 18-Aug-22 6:37 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-22 | Payment of Exercise | 9,227 | $11.08 | $102,235.00 | (3%) 350.49K to 341.26K | |
| 18-Aug-22 6:37 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-22 | Option Exercise | 26,680 | -- | -- | 8% 323.81K to 350.49K | |
| 18-May-22 4:06 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-22 | Payment of Exercise | 9,228 | $6.74 | $62,196.70 | (3%) 333.04K to 323.81K | |
| 18-May-22 4:06 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-22 | Option Exercise | 26,680 | -- | -- | 9% 306.36K to 333.04K | |
| 18-Feb-22 4:35 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-22 | Payment of Exercise | 1,020 | $8.84 | $9,016.80 | (< 1%) 307.38K to 306.36K | |
| 18-Feb-22 4:35 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-22 | Option Exercise | 2,488 | -- | -- | < 1% 304.89K to 307.38K | |
| 18-Nov-21 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-21 | Payment of Exercise | 1,234 | $47.25 | $58,306.50 | (< 1%) 305.62K to 304.38K | |
| 18-Nov-21 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-21 | Option Exercise | 2,488 | -- | -- | < 1% 303.13K to 305.62K | |
| 18-Aug-21 4:10 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-21 | Payment of Exercise | 1,028 | $49.48 | $50,865.40 | (< 1%) 304.16K to 303.13K | |
| 18-Aug-21 4:10 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-21 | Option Exercise | 2,487 | -- | -- | < 1% 301.67K to 304.16K | |
| 18-May-21 6:28 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-21 | Payment of Exercise | 862 | $53.66 | $46,254.90 | (< 1%) 302.53K to 301.67K | |
| 18-May-21 6:28 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-21 | Option Exercise | 2,488 | -- | -- | < 1% 300.04K to 302.53K | |
| 18-Feb-21 8:33 PM View: | Bridgebio Pharma, Inc. (BBIO) | 17-Feb-21 | Market Purchase | 8,000 | $62.50 | $500,000.00 | 3% 292.04K to 300.04K | |
| 18-Feb-21 8:33 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-21 | Payment of Exercise | 592 | $64.98 | $38,468.20 | (< 1%) 292.63K to 292.04K | |
| 18-Feb-21 8:33 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-21 | Option Exercise | 1,710 | -- | -- | < 1% 290.93K to 292.63K | |
| 18-Nov-20 7:43 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-20 | Payment of Exercise | 592 | $44.33 | $26,243.40 | (< 1%) 290.68K to 290.08K | |
| 18-Nov-20 7:43 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-20 | Option Exercise | 1,710 | -- | -- | < 1% 288.97K to 290.68K | |
| 18-Aug-20 6:59 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-20 | Payment of Exercise | 591 | $28.53 | $16,861.20 | (< 1%) 289.56K to 288.97K | |
| 18-Aug-20 6:59 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-20 | Option Exercise | 1,709 | -- | -- | < 1% 287.85K to 289.56K | |
| 05-Aug-20 6:55 PM View: | Bridgebio Pharma, Inc. (BBIO) | 04-Aug-20 | Sale (Planned) | 2,539 | $27.25 | $69,196.30 | (< 1%) 289.65K to 287.12K |